Wed, Apr 16, 2014, 11:57 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Cyclacel Pharmaceuticals, Inc. (CYCC) Message Board

behavioralsciencemodeling 7 posts  |  Last Activity: Mar 27, 2014 10:59 AM Member since: Sep 27, 2001
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • behavioralsciencemodeling by behavioralsciencemodeling Mar 27, 2014 10:59 AM Flag

    Am I missing something or is this a rather strange address for a biotech stock?

  • behavioralsciencemodeling by behavioralsciencemodeling Feb 14, 2014 9:14 AM Flag

    Does anyone have any comparison of these 2 possibly competing tests?

  • behavioralsciencemodeling by behavioralsciencemodeling Feb 10, 2014 3:03 PM Flag

    Does anyone know why the PGNX presentation was cancelled?

  • behavioralsciencemodeling by behavioralsciencemodeling Feb 7, 2014 8:24 AM Flag

    The only major event I could possibly imagine that would get this company back on track is the replacement of the CEO. He has just made too many poor decisions and there is no evidence to prove future decisions will be any better.
    His communication skills are, at best, poor. As a strategist, he has no map. He also has no past record of guiding a company to its full potential.
    The problem is Brad is the current Chairman and CEO. The board is impotent. The major stockholder has sold out. Who is left to make the intelligent tough decisions? No one.
    Unless one of the non-H&N trials reports out better than currently anticipated, this company and we as investors are toast!
    It's tough to see a technology and company dwindle to worthless because management is not up to standard. His presence also impairs the future of patients that could have benefitted from REO.

  • behavioralsciencemodeling by behavioralsciencemodeling Feb 6, 2014 11:59 AM Flag

    Are the above still with the company?

  • behavioralsciencemodeling by behavioralsciencemodeling Feb 6, 2014 8:25 AM Flag

    What is the short case? It must be powerful for short sellers to remain short in the face of Dr. Frost adding to his position every day.
    Right or wrong can anyone enlighten us to the short case?

  • behavioralsciencemodeling by behavioralsciencemodeling Feb 5, 2014 8:17 AM Flag

    It's a bit difficult to assess the impact of recent events on BRCA test revenues. Some will come from reduced payment by healthcare insurers. Possibly much more will come from the ability of competitors able to offer a competing test now that BRCA is no longer a protected target.

    Has anyone seen a comprehensive report addressing the above?

CYCC
3.17-0.06(-1.86%)Apr 16 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.